1. Home
  2. TZOO vs ABVC Comparison

TZOO vs ABVC Comparison

Compare TZOO & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travelzoo

TZOO

Travelzoo

N/A

Current Price

$6.35

Market Cap

60.3M

ML Signal

N/A

Logo ABVC BioPharma Inc.

ABVC

ABVC BioPharma Inc.

N/A

Current Price

$1.47

Market Cap

50.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TZOO
ABVC
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.3M
50.5M
IPO Year
2003
2009

Fundamental Metrics

Financial Performance
Metric
TZOO
ABVC
Price
$6.35
$1.47
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$16.00
N/A
AVG Volume (30 Days)
211.8K
48.5K
Earning Date
06-01-2026
06-17-2026
Dividend Yield
N/A
N/A
EPS Growth
27.71
7.14
EPS
0.39
N/A
Revenue
N/A
$509,589.00
Revenue This Year
$10.93
$735.18
Revenue Next Year
$9.25
N/A
P/E Ratio
$17.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.72
$0.61
52 Week High
$16.56
$4.02

Technical Indicators

Market Signals
Indicator
TZOO
ABVC
Relative Strength Index (RSI) 53.16 41.94
Support Level $4.72 $1.15
Resistance Level $7.45 $1.52
Average True Range (ATR) 0.44 0.12
MACD 0.10 0.02
Stochastic Oscillator 61.36 56.63

Price Performance

Historical Comparison
TZOO
ABVC

About TZOO Travelzoo

Travelzoo acts as a publisher of travel and entertainment offers. It operates in four segments. Travelzoo North America segment, which is the key revenue driver, consists of operations in Canada and the U.S.; Travelzoo Europe segment consists of operations in France, Germany, Spain, and the U.K.; Jack's Flight Club segment consists of subscription revenue from premium members to access and receive flight deals from Jack's Flight Club via email or via Android or Apple mobile applications; and New Initiatives consists of Travelzoo's licensing activities in Asia Pacific territories. It derives its revenue through advertising fees including listing fees paid by travel, entertainment, and local businesses to advertise their offers on the company's media properties.

About ABVC ABVC BioPharma Inc.

ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

Share on Social Networks: